Stay updated on ARGX-110 with Azacytidine in AML Clinical Trial

Sign up to get notified when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARGX-110 with Azacytidine in AML Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the page.
    Difference
    0.1%
    Check dated 2026-03-18T17:50:26.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:52:32.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Site update adds Revision: v3.4.2 and removes the government funding status notice (Revision: v3.4.1).
    Difference
    0.4%
    Check dated 2026-02-11T02:41:18.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added a government funding notice about potential delays and updated operations status information with a link to opm.gov. Updated the site revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T00:26:48.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Glossary toggle added; QC-related metadata updated to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the prior QC label and version, and a 'No FEAR Act Data' item is now shown instead of the former 'No FEAR Act data' entry.
    Difference
    0.2%
    Check dated 2026-01-27T23:58:16.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    The page displays Revision: v3.3.4, replacing Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T01:15:32.000Z thumbnail image

Stay in the know with updates to ARGX-110 with Azacytidine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.